Patent · US Active

Methods for use of epinephrine fine particles for treatment of conditions responsive to epinephrine

US10159656B2 · kind B2 · utility

6Cited by
15References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 7, 2016
Grant dateDec 25, 2018
Priority date
Expiry dateOct 7, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions including epinephrine fine particles, including epinephrine nanoparticles or nanocrystals and epinephrine microparticles or microcrystals, and methods for therapeutic use of the compositions for the treatment of conditions responsive to epinephrine such as a cardiac event or an allergic reaction, particularly anaphylaxis. The epinephrine fine particles can be incorporated into orally-disintegrating and fast-disintegrating tablet pharmaceutical formulations and can significantly increase the sublingual bioavailability of epinephrine, and thereby reduce the epinephrine dose required.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.